International Cartilage Repair Society

Similar documents
QUANTITATIVE DETERMINATION OF HUMAN CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) ELISA

Serum Level of Cartilage Oligomeric Matrix Protein as a Screening Modality for Osteoarthritis among Knee Joint Pain Patients

Serum cartilage oligomeric matrix protein (scomp) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis

Diagnostic and prognostic value of some biochemical markers in early knee osteoarthritis

Title: Serum Cartilage Oligomeric Matrix Protein (scomp) is Elevated in Patients with Knee Osteoarthritis: A Systematic Review and Meta-Analysis

O steoarthritis (OA) is a multifactorial, structurally

E. Larsson, H. Erlandsson Harris, J. C. Lorentzen, A. Larsson 1, B. Månsson 2, L. Klareskog and T. Saxne 2

International Cartilage Repair Society

ANALYSIS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) IN SYNOVIAL FIBROBLASTS AND SYNOVIAL FLUIDS

Mouse Adiponectin Immunoassay Kit

See external label 2 C-8 C Σ=96 tests Cat # 3171Z. Free Estriol. Cat # 3171Z. Enzyme Linked Immunosorbent Assay

ScienceDirect. The impact of the severity of knee osteoarthritis on the postural stability

Mercodia Equine Insulin ELISA

The Effect of Anterior Knee Pain on Serum Cartilage Oligomeric Matrix Protein and Muscular Cocontraction During Running

EXOTESTTM. ELISA assay for exosome capture, quantification and characterization from cell culture supernatants and biological fluids

See external label 2 C-8 C Σ=96 tests Cat # 6101Z. Cortisol. Cat # 6101Z

Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners

GLUCOSE CONCENTRATION INCREASES IGF EXPRESSION FROM SYNOVIAL MEMBRANE

Introduction to Biomedical Engineering

Received: 9 Oct 2002 Revisions requested: 20 Nov 2002 Revisions received: 12 Mar 2003 Accepted: 19 Mar 2003 Published: 29 Apr 2003

A Comparative Study of Ultrasonographic Findings with Clinical and Radiological Findings of Painful Osteoarthritis of the Knee Joint

TSH Receptor Autoantibody ELISA

Potential biomarkers and study design for joint health: How to quantify mobility enhancing effects of foods. Dr. S. Buchwald-Werner 23.

Assay Kit for Measurement of Proteoglycan. (Sulfated Glycosaminoglycan Quantification Kit)

NBQX, An AMPA/Kainate Glutamate Receptor Antagonist, Alleviates Joint Disease In Models Of Inflammatory- And Osteo- Arthritis.

Hyaluronan Quantification Kit

Zhi-jun Zhao, Qiang Li, Li Ma, Ji-quan Li and Li-qing Xu *

Osteoarthritis What is new? Dr Peter Cheung, Rheumatologist, NUHS

O steoarthritis (OA) and other arthritic diseases involving

Anti-inflammatory properties of SM04690, a small molecule inhibitor of the Wnt pathway as a potential treatment for knee osteoarthritis

IBEX Pharmaceuticals Inc.

Insulin (Porcine/Canine) ELISA

Disclosures: A.G. Bajpayee: None. A.M. Scheu: None. R.M. Porter: None. A.J. Grodzinsky: None.

SODIUM HYALURONATE 2% + MANNITOL. Flexible Treatment Scheme

Triiodothyronine (T3) ELISA

Bovine Insulin ELISA

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and

Mercodia Porcine C-peptide ELISA

Rat C-peptide ELISA. For the quantitative determination of C-peptide in rat serum

Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04690) as a Potential Disease Modifying Treatment for Knee Osteoarthritis

Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis

Prothrombin (Human) ELISA Kit

News Release. Merck KGaA, Darmstadt, Germany, Presents New Osteoarthritis Data at OARSI 2018 World Congress. April 17, 2018

Mitsuru Hanada 1, Masaaki Takahashi 2, Hiroki Furuhashi 1, Hiroshi Koyama 1 and Yukihiro Matsuyama 1. Research Article

Rat Insulin ELISA. For the quantitative determination of insulin in rat serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

Rat C-peptide ELISA. For the quantitative determination of C-peptide in rat serum. For Research Use Only. Not For Use In Diagnostic Procedures.

Human Urokinase / PLAU / UPA ELISA Pair Set

Instructions for Use. Tg Antibody ELISA

RayBio Human Granzyme B ELISA Kit

20X Buffer (Tube1) 96-well microplate (12 strips) 1

Mercodia Rat C-peptide ELISA

Cortisol (Sheep) ELISA Kit

SensoLyte Rh110 Cathepsin K Assay Kit *Fluorimetric* Revision#1.2 Last Updated: May 2017 Catalog # Kit Size

Thyroxine (T4) Human ELISA Kit

Page 1 of 2. Standard curve of Human IFN gamma ELISA Ready- SET-Go! Product Information Contents: Human IFN gamma ELISA Ready- SET-Go!

DBC 25-Hydroxyvitamin D

Mercodia Porcine C-peptide ELISA

Human LDL ELISA Kit. Innovative Research, Inc.

Total Thyroxine ELISA (T4)

Mouse C-peptide ELISA

Apolipoprotein A-1 ELISA

IBEX Pharmaceuticals Inc.

Knee Articular Cartilage in an Asymptomatic Population : Comparison of T1rho and T2 Mapping

Herpes Simplex Virus 2 IgM HSV 2 IgM

WHO Prequalification of Diagnostics Programme PUBLIC REPORT

Porcine/Canine Insulin ELISA

Discovery of a Small Molecule Inhibitor of the Wnt Pathway as a Potential Disease Modifying Treatment for Knee Osteoarthritis

See external label 2 C-8 C Σ=96 tests Cat # 3122Z MICROWELL ELISA THYROID STIMULATING HORMONE (TSH) ENZYME IMMUNOASSAY TEST KIT TSH.

25(OH) Vitamin D ELISA (BD-220BA), 192 Tests

AN INTRODUCTION TO REGENERATIVE MEDICINE

IV2-113E Use by. Invitron Glargine ELISA Kit REF LOT IVD. Definitions. English. For in-vitro diagnostic use. Instructions for use.

colorimetric sandwich ELISA kit datasheet

For the quantitative measurement of ATP Synthase Specific activity in samples from Human, Rat and Cow

Nori Rabbit IL-2 ELISA Kit DataSheet

therapy, and means to elucidate disease mechanisms will be provided.

Mouse Ultrasensitive Insulin ELISA

Clinical Biochemistry

Human LDL Receptor / LDLR ELISA Pair Set

DUROLANE: The Science of the Single Injection

Osteoarthritis. Dr Anthony Feher. With special thanks to Dr. Tim Williams and Dr. Bhatia for allowing me to use some of their slides

SensoLyte 520 Cathepsin K Assay Kit *Fluorimetric*

Thyroid Stimulating Hormone (TSH) ELISA Catalog No. GWB , legacy id (96 Tests)

Mouse C-peptide ELISA

SensoLyte Generic MMP Assay Kit *Colorimetric*

Disclosures: C.B. Raub: None. B.C. Hansen: None. T. Yamaguchi: None. M.M. Temple-Wong: None. K. Masuda: None. R.L. Sah: None.

HbA1c (Human) ELISA Kit

EXPRESSION OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN ARTICULAR CARTILAGE IN RESPONSE TO BONE MORPHOGENETIC PROTEIN-7 AND TUMOUR NECROSIS FACTOR

See external label 96 tests HSV 2 IgA. Cat #

REVIEW I-Flex and Management of Inflammation in Osteoarthritis

Omega-3 Fatty Acids Mitigate Obesity-induced Osteoarthritis And Accelerate Wound Repair

Relationships amongst osteoarthritis biomarkers, dynamic knee joint load, and exercise: results from a randomized controlled pilot study

ab Complex II Enzyme Activity Microplate Assay Kit

Active-B12 (Holo-TC) ELISA KIT

QP in weight bearing cartilage follow known load distribution patterns in the fetlock [4-6]. EAG coefficients at anterior (EAG1, EAG2) and

Serum Amyloid A ELISA

Life. Uncompromised. The KineSpring Knee Implant System Surgeon Handout

Efficacy of Intra-Articular Injection of Celecoxib in a Rabbit Model of Osteoarthritis

DECREASE JOINT PAIN IMPROVE JOINT FUNCTION Treatment of Osteoarthritis with Ostenil

Evaluation and Treatment of Knee Arthritis Classification of Knee Arthritis Osteoarthritis Osteoarthritis Osteoarthritis of Knee

Transcription:

OsteoArthritis and Cartilage (2005) 13, 34e38 ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.joca.2004.09.007 Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults 1 Annegret Mündermann Ph.D.yz*, Chris O. Dyrby Eng.yz, Thomas P. Andriacchi Ph.D.yzx and Karen B. King Ph.D.k y Department of Mechanical Engineering, Stanford University, Stanford, CA, USA z Bone and Joint Center, Palo Alto VA, Palo Alto, CA, USA x Department of Orthopedic Surgery, Stanford University Medical Center, Stanford, CA, USA k Department of Medicine, University of California San Francisco, San Francisco, CA, USA Summary International Cartilage Repair Society Objective: To test the hypothesis that physiological cyclic loading during a 30-min walking exercise causes an increase in serum cartilage oligomeric matrix protein (COMP) concentration in a healthy population. Methods: Blood samples (5 ml) were drawn from 10 physically active adults immediately before and after, and 0.5 h, 1.5 h, 3.5 h and 5.5 h after a 30-min walking exercise on a level outdoor walking track at self-selected normal speed. On a separate day, blood samples were drawn from the same 10 subjects during 6 h while they were resting in a chair. Serum COMP concentrations were determined using a commercial enzyme-linked immunosorbent assay (COMP Ò ELISA). An activity monitor was used to record basic timeedistance measurements of gait. Serum COMP concentrations within the exercise protocol and within the resting protocol were compared using separate repeated measures analyses of variance (a Z 0.05). Results: In the exercise protocol, a first increase (9.7%; P Z 0.003) occurred immediately after the walking exercise. A second increase in serum COMP concentration (7.0%; P Z 0.024) occurred 5.5 h after the walking exercise. In the resting protocol, the concentration at baseline was significantly higher than at all subsequent time points (8.2%; P! 0.050). Serum COMP concentration decreased from the 3.5-h to the 5.5-h sample (ÿ4.8%; P Z 0.012). Conclusions: Even a moderate walking activity can significantly influence serum COMP concentration. The immediate response points to a diffusion time of COMP fragments from cartilage to the blood of 30 min or less. The response at 5.5 h indicates a metabolic delay for COMP in the range of 5 h to 6 h. ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved. Key words: COMP, Cartilage, Walking, Exercise. Introduction Cartilage oligomeric matrix protein (COMP) is a prominent constituent of articular cartilage 1. Increased serum concentrations of COMP fragments have been reported for patients with knee osteoarthritis (OA) 2e5 and early rheumatoid arthritis (RA) 6,7. It has thus been suggested 4 that patients with high levels of COMP in serum might represent individuals with increased degradation of their articular cartilage. Indeed, patients with greater serum COMP concentration experience a faster progression of their disease 6e10. It has been proposed that COMP molecules are important for maintaining the properties and integrity of the collagen network 11 and contribute to the material properties of biological tissue 12. Increases in blood serum 1 Support: AnaMar Medical AB (Lund, Sweden) provided COMP ELISA kits. Dynastream Innovations Inc. (Cochrane, Canada) provided an activity monitor. *Address correspondence and reprint requests to: Dr. Annegret Mündermann, Durand Building 205, Stanford University, Stanford, CA 94305-3030. Tel: 1-650-724-9684; Fax: 1-650-725-1587; E-mail: amuender@stanford.edu Received 17 April 2004; revision accepted 24 September 2004. concentrations of COMP have been reported 13 in response to strenuous running exercise in healthy adults, and COMP levels remain elevated for up to 1 h after completion of the exercise. The loss of COMP fragments from the cartilage (indicated by increased serum levels) following exercise is important since COMP molecules may also transfer forces from the cartilage matrix to the cell, and thus are involved in the regulation of tissue synthesis and degradation 14. Hence, COMP may be especially important for linking biological or pathogenic processes to mechanical loading of articular cartilage. However, the diffusion time of COMP fragments from cartilage to the blood and the metabolic delay for COMP in a healthy population have not been specified. While increased mechanical loads at the knee during walking have been related to the progression of knee OA over a 6-year period 15, it is not known whether everyday activities such as walking for a short period will cause a change in serum COMP concentration. In a healthy population, such activities may cause an increase in serum COMP concentration that may indicate normal adaptation to altered functional demand. Thus, the purpose of this study was to test the hypothesis that a 30-min walking exercise causes an increase in serum COMP concentration. 34

Osteoarthritis and Cartilage Vol. 13, No. 1 Methods POPULATION Ten adults (five male, five female; age: 31.9 G 5.9 years; height: 1.74 G 0.10 m; mass: 70.7 G 15.9 kg; body mass index (BMI): 23.1 G 2.8 kg/m 2 ; Table I) participated in this study after giving informed consent in accordance with the Institutional Review Board at Stanford University. All subjects were physically active, had no history of injuries to the lower extremities, and were free of pain for at least 6 months prior to the experiment. PROCEDURE Subjects were asked to limit their physical activity 36 h prior to the experiment. On the day of the experiment, subjects consumed breakfast within 1 h of waking, and the experiment started within 3e4 h of waking. Subjects were seated in a chair for 15 min immediately before the experiment. Five-milliliter blood samples were drawn by a certified research nurse from the same antecubital vein immediately before, immediately after, and 0.5 h, 1.5 h, 3.5 h, and 5.5 h after a 30-min walking exercise. Subjects consumed lunch immediately following the 1.5-h blood draw. During the walking exercise of the exercise protocol, subjects walked at their self-selected normal speed on a level paved outdoor walking track. An accelerometer based activity monitor (AMP331; Dynastream Innovations Inc., Cochrane, Canada) was attached to the subjects right ankles to record basic timeedistance measurements of gait including total step count, distance and average walking speed, cadence and stride length. Subjects performed office tasks in a seated posture after the 30-min walking exercise and were asked to perform a minimal amount of physical activity after completing the 30-min walking exercise. On a separate day, data were collected for a resting protocol. Similarly to the exercise protocol, subjects selflimited their physical activity 36 h prior to the experiment, consumed breakfast within 1 h of waking, and the experiment started within 3e4 h of waking. Subjects were seated in a chair for 15 min immediately before the experiment. Blood samples were drawn at the same time points as in the exercise protocol over the course of 6 h while they were resting in a chair. An activity monitor was used to quantify the number of steps taken during the 6 h of the resting protocol. ENZYME-LINKED IMMUNOSORBENT ASSAY Blood was collected and allowed to clot for 30 min. Sera were separated and frozen to ÿ20(c within 1 h of collection and then transferred for storage at ÿ80(c until assayed. Serum COMP concentrations were determined using a commercial enzyme-linked immunosorbent assay (COMP Ò ELISA; AnaMar Medical AB, Lund, Sweden). Briefly, 25 ml of six standards, diluted human control sera, as well as the diluted subject sera were added to an anti- COMP coated plate (mouse monoclonal antibodies) and incubated with 100 ml enzyme conjugate peroxidaseeanti- COMP (mouse monoclonal antibodies, approximately 10 mg/ml) for 2 h at room temperature. After rinsing, the bound antibody was incubated with an enzyme substrate (tetramethylbenzidine) for 15 min at room temperature followed by incubation with stop solution (0.5 M H 2 SO 4 ). The light absorbance of the reaction was read at 450 nm in a plate reader (Bio-Rad 550; Bio-Rad Laboratories, Hercules, CA). An in-house cubic spline regression algorithm written in Mathematica version 4.1 (Wolfram Research Inc., Champaign, IL) was used to define the standard curve of light absorbance vs COMP concentration and to interpolate serum COMP concentrations of the samples. Investigators were blinded to the samples, which were analyzed in duplicate and in random order. The detection limit of the assay was!0.1 Units/liter (U/l), and the intra-assay and inter-assay coefficients of variation were!1.9% and!2.7%, respectively (10 U/l convert to approximately 1 mg/ml) 16. Differences due to inter-assay variation were eliminated by comparing concentrations within subjects and by testing all samples of any subject on the same plate. STATISTICAL ANALYSIS All statistical computations were performed using SPSS 11.5 software (SPSS Inc., Champaign, IL). Descriptive statistics, sample means, and standard deviation for serum COMP concentrations and basic timeedistance measures of gait were calculated. Serum COMP concentrations within the exercise protocol and within the resting protocol were compared using separate repeated measures analyses of variance (ANOVAs). Repeated measures Student s t tests were used for post hoc comparisons. The significance level a for all statistical tests was set at 0.05. Results At baseline of the exercise protocol (i.e., immediately before the 30-min walking exercise), the mean serum COMP concentration was 9.98 G 3.38 U/l. While female subjects had significantly lower serum COMP concentrations (6.72 G 1.55 U/l) than male subjects (11.59 G 2.35 U/l; P Z 0.005), all individual serum COMP concentrations at baseline were within the previously reported normal distribution 16 (Fig. 1). Serum COMP concentrations immediately after the 30-min walking exercise were elevated, on average, by 9.7% (Figs. 1 and 2; P Z 0.003) and returned to the baseline concentration 30 min later. A second increase in serum COMP concentration was observed 5.5 h after the 30- min exercise [Fig. 2(a); P Z 0.024]. 35 Table I Mean (G1 SD) of demographic data and basic timeedistance measurements during the 30-min walking exercise for all subjects by gender Gender Age (years) Height (m) Mass (kg) BMIy (kg/m 2 ) Speed (m/s) Distance (m) Number of steps Cadence (steps/min) Stride length (m) Male, N Z 5 31.4 (4.5) 1.82 (0.06) 83.4 (11.4) 25.2 (1.8) 1.47 (0.12) 2685.2 (217.0) 3369.2 (231.5) 110.8 (8.6) 0.80 (0.04) Female, N Z 5 32.4 (7.6) 1.66* (0.06) 57.9* (6.0) 20.9* (1.8) 1.52 (0.11) 2812.6 (171.2) 3644.8* (69.1) 117.8 (2.3) 0.77 (0.06) * Significantly different from male subjects (P! 0.050) based on two-tailed Student s t tests using SPSS 11.5 software (SPSS Inc., Champaign, IL). y BMI Z mass (kg)/height (m) 2.

36 A. Mündermann et al.: COMP and in vivo cyclic loading Fig. 1. Comparison of serum COMP concentrations at the first two time points of the exercise protocol in the present study with the normal distribution data from the manufacturer: (a) normal distribution (N Z 336) of serum COMP concentration in blood donors provided by the manufacturer 16 and risk of joint destruction in RA (!12 U/l: low; 12e15 U/l: increasing; O15 U/l: high) 9 ; (b) individual serum COMP concentration immediately before and immediately after a 30-min walking exercise measured in the present study (N Z 10). Note that serum COMP concentration of all subjects increased and that three subjects would be classified into higher risk categories after the 30-min walking exercise. During the 30-min walking exercise, subjects took, on average, 3507 G 217 steps to travel an average distance of 2748.9 G 196.1 m (Table I). Average walking speed, cadence and stride length for all subjects during the 30-min walking exercise were 1.49 G 0.11 m/s, 114.3 G 7.0 steps/ min and 0.78 G 0.05 m, respectively. While the female subjects were significantly lighter and shorter and took more steps (P Z 0.002, P Z 0.004, and P Z 0.034, respectively) than male subjects, these two groups did not differ in age, self-selected walking speed, distance traveled, cadence, or stride length (P O 0.050; Table I). The magnitude of the increases in COMP concentrations immediately after and 5.5 h after the 30-min walking exercise was not related to gender, age, height, mass, BMI, or any of the basic timeedistance gait measures (P O 0.050; linear regression analysis). At baseline of the resting protocol the mean serum COMP concentration was 8.89 G 2.75 U/l. This concentration was not significantly different from the baseline concentration of the exercise protocol (P Z 0.620). In the resting protocol, the concentration at baseline was significantly higher than at all subsequent time points [8.2%; P! 0.050; Fig. 2(b)]. Interestingly, serum COMP concentration further decreased from the 3.5-h to the 5.5-h sample (ÿ4.8%; P Z 0.012). During the resting protocol (duration: 6 h), subjects took on average 505 steps and traveled an average distance of 210.0 m. Discussion The results of this study showed that an activity as simple as walking for 30 min can cause elevated levels of COMP in Fig. 2. (a) Mean (SD) serum COMP concentration before (ÿ0.5 h) and up to 5.5 h after 30-min walking exercise (N Z 10 subjects); (b) mean (SD) serum COMP concentration during 6 h of resting in a chair for the same 10 subjects. *Significantly different from baseline; ysignificantly different from preceding time point (a Z 0.05). Serum COMP concentrations after exercise were normalized to serum COMP concentration at baseline (before exercise) for each subject for visual presentation. Comparisons of serum COMP concentrations before and after exercise and between resting time points were performed with repeated measures ANOVA (a Z 0.05) using SPSS 11.5 software (SPSS Inc., Champaign, IL). serum. The number of steps taken during the 30-min exercise in this study corresponds to approximately 30% of the average number of steps taken per day in a healthy population 17. In comparison, simply traveling to the clinic for blood testing may represent a similar portion of daily walking activity in a mostly sedentary population of patients with knee pain. Thus, uncontrolled activity such as walking to or within the clinic prior to a diagnostic blood test may alter serum COMP concentrations. Average serum COMP concentrations in the current study were lower than values reported for patients with OA 18,19, patients with knee OA 20 and patients with early RA 7 using the same assays. While all baseline values were within the normal distribution of a large sample of blood donors 16 [Fig. 1(a)], three of our subjects would be classified into higher categories of risk for joint destruction for RA patients 9 after the 30-min walking exercise [Fig. 1(b)]. Similarly, it is possible that the effect of an OA or RA patient walking to the clinic could also bias the result of the diagnostic test. To our knowledge, the diffusion time of COMP fragments from cartilage to the blood and the metabolic delay for COMP in a healthy population are unknown. Consequently, repeated blood sampling over the course of 6 h was chosen because the time delay between physiological cyclic loading of the joints of the lower extremity during a walking exercise and the consecutive increase in serum COMP concentration was not known. Neidhart et al. 13 investigated the kinetics of COMP concentration in serum before, during, immediately after and 2 h after a marathon run. Serum

Osteoarthritis and Cartilage Vol. 13, No. 1 COMP concentrations increased throughout the run and decreased within 2 h after the run. Neidhart et al. 13 did not take additional blood samples more than 2 h after the run on the same day. Nevertheless, our observations are consistent with these results. We suggest that the immediate elevation of serum COMP concentration after 30 min of mild exercise and during a marathon run reflects enhanced diffusion of COMP fragments from the cartilage to the blood due to the physiological cyclic joint loading corresponding to a diffusion time of COMP of 30 min or less. Moreover, the immediate increases in serum COMP concentration after physiological cyclic loading indicate that free COMP antigens are indeed also present in the living tissue of healthy adults. In our study, we observed a second increase in serum COMP concentration 5.5 h after the 30-min exercise. It has previously been shown 14,21 that COMP expression is enhanced following cyclic confined and unconfined compression (10% amplitude, 0.5 Hz) of bovine articular cartilage explants in situ for 18 h and 45 h. Thus, although load was applied over a much shorter period (30 min) in the current study, the increase in serum COMP concentration following physiological cyclic loading in vivo such as the 30- min walking exercise of healthy adults (females and males) may in fact reflect increased tissue metabolism. While COMP is a proposed marker for cartilage degradation 4, and increased serum COMP concentrations after exercise thus likely reflect increased COMP catabolism; the anabolic activity of the tissue is unknown. However, everyday activities such as a 30-min walking exercise will most likely stimulate cartilage turnover rather than initiate cartilage degradation in a healthy population. Further studies are necessary to quantify anabolic activity of cartilage following a walking exercise. While serum COMP concentrations increased immediately and 5.5 h after the 30-min walking exercise, in the resting protocol serum COMP concentrations decreased from the ÿ0.5-h (baseline) value to the 0-h value and further decreased to the 5.5-h value. Thus, the increases observed in the exercise protocol are clearly due to the 30-min walking exercise and suggest a metabolic delay in the order of 5e6 h. The observed increases in the exercise protocol might have been even greater had the subjects not been required to travel to the blood clinic. In the resting protocol, the concentration at baseline was significantly higher than at all subsequent time points suggesting an increase in serum COMP concentration following walking activity required to travel to a blood clinic followed by a decrease after resting. A previous study 22 reported decreased serum COMP concentrations during bed rest at night reaching the lowest levels around 5 am. Hence, we recommend that future biomarker studies draw subjects blood in the morning and after the subject was in a seated posture for at least 30 min. Wong et al. 14 suggested that cyclic loading has an important regulatory function in cartilage matrix remodeling. Our study is a first attempt to link serum COMP concentration to physiological cyclic loading in vivo. This is the first study to report diffusion time of COMP fragments from cartilage to the blood, metabolic delay for COMP, and the effect of controlled walking exercise on serum COMP concentration in a healthy population. The results of this study showed that controlling physical activity prior to blood sampling for biomarker tests is critical and suggest a diffusion time of COMP fragments to the blood of 30 min or less and a metabolic delay for COMP in the range of 5 h to 6 h in the exercise protocol used in this study. Acknowledgements We thank Louise McManus from the Clinical Studies Unit at the Palo Alto VA Health Care System, Palo Alto, CA for taking the blood samples; AnaMar Medical AB for providing the ELISA kits; and Dynastream Innovations Inc. for providing the activity monitor. References 1. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992;267: 6132e6. 2. Clark AG, Jordan JM, Vilím V, Renner JB, Dragomir AD, Luta G, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 1999;42:2356e64. 3. Jordan JM, Luta G, Stabler T, Renner JB, Dragomir AD, Vilím V, et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum 2003;48:675e81. 4. Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Häuselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151e60. 5. Pavelka K, Forejtová Š, Olejárová M, Gatterová J, Šenolt L, Špaček P, et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 2004;12: 277e83. 6. Forslind K, Eberhardt K, Jonsson A, Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 1992;31:593e8. 7. Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003;32: 156e61. 8. Vilím V, Olejárová M, Macháĉek S, Gatterová J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002;10:707e13. 9. Lindqvist EK, Eberhardt K, Heinegård D, Saxne T. Serum COMP for risk assessment of joint destruction in early rheumatoid arthritis (Abstract). In: Proceedings of EULAR 2002, June, Stockholm, Sweden 2002;60. 10. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 2004;50:2479e88. 11. Rosenberg K, Olsson H, Mörgelin M, Heinegård D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 1998;273:20397e403. 12. Smith RK, Gerard M, Dowling B, Dart AJ, Birch HL, Goodship AE. Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in 37

38 A. Mündermann et al.: COMP and in vivo cyclic loading determining function-specific mechanical characteristics of locomotor tendons. Equine Vet J Suppl 2002; 34:241e4. 13. Neidhart M, Müller-Ladner U, Frey W, Bosserhoff AK, Colombani PC, Frey-Rindova P, et al. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 2000;8:222e9. 14. Wong M, Siegrist M, Cao X. Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins. Matrix Biol 1999;18: 391e9. 15. Miyazaki T, Wada M, Kawahara H, Sato M, Baba H, Shimada S. Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis. Ann Rheum Dis 2002;61: 617e22. 16. AnaMar Medical AB. COMPª ELISA Enzyme Immunoassay: Directions for use. 3e11. 17. Sequeira MM, Rickenbach M, Wietlisbach V, Tullen B, Schutz Y. Physical activity assessment using a pedometer and its comparison with a questionnaire in a large population survey. Am J Epidemiol 1995;142: 989e99. 18. Petersson IF, Boegård T, Svensson B, Heinegård D, Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998;37:46e50. 19. Petersson IF, Boegård T, Dahlström J, Svensson B, Heinegård D, Saxne T. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthritis Cartilage 1998;6:33e9. 20. King KB, Lindsey CT, Dunn TC, Ries MD, Steinbach LS, Majumdar S. A study of the relationship between molecular biomarkers of joint degeneration and the magnetic resonance-measured characteristics of cartilage in 16 symptomatic knees. Magn Reson Imaging 2004;22:1117e23. 21. Giannoni P, Siegrist M, Hunziker EB, Wong M. The mechanosensitivity of cartilage oligomeric matrix protein (COMP). Biorheology 2003;40:101e9. 22. Andersson M, Jpnsson N, Petersson IF, Heinegård D, Saxne T. Diurnal variation of serum-comp in individuals with knee pain and osteoarthritis (Abstract). In: Proceedings of the EULAR 2002, June, Stockholm, Sweden 2002;48.